ARCA biopharma, Inc. (ABIO) Financials
Stock symbol ABIO is outdated, potentially delisted? Maybe it is available on other exchange?
ABIO Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| Dec. 31, 2023 | 37.9 million | 841000 |
| Sept. 30, 2023 | 39.2 million | 1.2 million |
| June 30, 2023 | 41.1 million | 1.8 million |
| March 31, 2023 | 42.1 million | 1.5 million |
ABIO Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| Dec. 31, 2023 | -1.1 million | 141000 |
| Sept. 30, 2023 | -1.7 million | 154000 |
| June 30, 2023 | -694000 | 187000 |
| March 31, 2023 | -1.6 million | 204000 |
ABIO Net Income
No data available :(
ABIO Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| Dec. 31, 2023 | 37.4 million | - | 204000 |
| Sept. 30, 2023 | 38.5 million | - | 224000 |
| June 30, 2023 | 40.2 million | - | 243000 |
| March 31, 2023 | 40.9 million | - | 262000 |
ABIO Shares Outstanding
ABIO Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| Dec. 31, 2023 | - | 47000 | 1.5 million | - |
| Sept. 30, 2023 | - | 322000 | 1.6 million | - |
| June 30, 2023 | - | 254000 | 1.7 million | - |
| March 31, 2023 | - | 390000 | 1.4 million | - |
ABIO Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| Dec. 31, 2023 | - | 23000 |
| Sept. 30, 2023 | - | 30000 |
| June 30, 2023 | - | 29000 |
| March 31, 2023 | - | 29000 |
ABIO
Price: $28.80
52 week price:
Forward Dividend Yield: 5.52%
Payout Ratio: -324.49%
Dividend Per Share: 1.59 USD
Earnings Per Share: -0.49 USD
P/E Ratio: -4.32
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 21900
Ebitda: -14.2 millionMarket Capitalization: 40.8 million
Years Paying Dividends: 1